Nona Biosciences
Larissa S. is an experienced professional in business development and project management within the healthcare and diagnostics sectors. Currently serving as Associate Director of Business Development at Nona Biosciences since January 2023, Larissa previously held the position of Senior Manager of Business Development at Eutropics. Larissa has also worked as Director of Business Development and Project Management at Sabin Medicina Diagnóstica, with earlier roles including New Business Development Lead and Clinical Laboratory Scientist. Educational qualifications include an MBA in Business Administration and STEM Business Analytics from Hult International Business School, a Lean Six Sigma Green Belt Certification from FM2S Educação e Consultoria, and an MBA in Health Administration from FGV - Fundação Getulio Vargas. Larissa holds a Bachelor of Science in Biomedical Sciences from Universidade Feevale.
This person is not in the org chart
This person is not in any teams
Nona Biosciences
Nona Biosciences is a global biotechnology company committed to providing a total solution for partners worldwide, from academies, biotech startups to biopharma giants. The integrated antibody discovery services range from antigen preparation, animal immunization, single B cell screening, to antibody lead generation and engineering, developability assessment and pharmacological evaluation, leveraging the advantages of Harbour Mice® platforms and the experienced therapeutic antibody discovery team. Harbour Mice® generates fully human monoclonal antibodies in two heavy and two light chains (H2L2) format, as well as heavy chain only (HCAb) format. Integrating Harbour Mice® and a single B cell cloning platform, Nona Biosciences is focused on driving global inventions of transformative next-generation drugs by diversified partnership strategies including co-discovery, platform and antibody discovery, and platform license. The values of the antibody discovery platforms and flexible partnership models have been well validated by more than 50 industry and academic partners within over 200 projects.